Novavax (NVAX) Current Assets (2010 - 2026)
Novavax's Current Assets was $771.1 million in Q2 2026, down 16.1% from $919.51 million a year earlier and down 9.4% from the prior quarter.
Analysis
Novavax (NVAX) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Novavax came in at $978.28 million, down 13.3% from FY2024.
- Current Assets has now declined for four consecutive years, with a five-year compound annual growth rate of -4.8% (FY2020 to FY2025).
- In earlier years, Current Assets was $1.13 billion in FY2024 (-1.3%), $1.14 billion in FY2023 (-32.8%), $1.7 billion in FY2022 (-21.0%) and $2.16 billion in FY2021 (+72.7%).
- The Q2 2026 figure marks the lowest quarterly Current Assets since Q1 2024.
- Compared with a year earlier, Current Assets has declined for five straight quarters, with an average decline of 4.9% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q3 2021 (growth of 223.9%); the worst was Q1 2023 (a decline of 58.6%).
- Per Business Quant data, NVAX's Current Assets in the three quarters before Q2 2026 was $850.82 million (Q1 2026), $978.28 million (Q4 2025) and $974.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | 771.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 771.10 Mn |
| Mar 31, 2026 | 850.82 Mn |
| Dec 31, 2025 | 978.28 Mn |
| Sep 30, 2025 | 974.59 Mn |
| Jun 30, 2025 | 919.51 Mn |
| Mar 31, 2025 | 868.03 Mn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 1.10 Bn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 727.12 Mn |
| Dec 31, 2023 | 1.14 Bn |
| Sep 30, 2023 | 1.01 Bn |
| Jun 30, 2023 | 1.13 Bn |
| Mar 31, 2023 | 971.03 Mn |
| Dec 31, 2022 | 1.70 Bn |
| Sep 30, 2022 | 1.76 Bn |
| Jun 30, 2022 | 2.14 Bn |
| Mar 31, 2022 | 2.35 Bn |
| Dec 31, 2021 | 2.16 Bn |
| Sep 30, 2021 | 2.17 Bn |
API Access
Novavax Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=NVAX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();